TL;DR
Medical device manufacturer insurance is built to pass GPO vendor schedules (Vizient, Premier, HealthTrust) and hospital procurement requirements: $5M general liability, $10M products liability, additional-insured on a primary and non-contributory basis, waiver of subrogation, and 30-day notice - all enforced through Symplr/Reptrax credentialing. Cyber sizing depends on device class and connectivity, not on revenue.
Medical Device Manufacturers · Texas
GPO supplier agreements (Vizient, Premier, HealthTrust) require $5M general liability, $10M products liability, additional-insured wording for the GPO and member hospitals on a primary/non-contributory basis, waiver of subrogation, and 30-day notice - every term enforced through Symplr/Reptrax credentialing.
Most mid-market device manufacturers find that a generic manufacturers package does not satisfy GPO insurance schedules. We help rebuild programs that pass vendor credentialing and respond to the long-tail products risk specific to FDA-regulated medical devices.
Problem 01 · GPO compliance
Symplr/Reptrax and similar platforms enforce GPO and hospital insurance requirements by blocking purchases when COIs do not match the schedule. The product passes evaluation, the supplier passes registration - and the hospital simply cannot order from you. Most suppliers learn about the problem only when sales drop unexpectedly.
GPO floors are typically $5M general liability, $10M products liability, $25M aggregate for higher-risk implantables, with additional-insured for the GPO and member hospitals on a primary and non-contributory basis, waiver of subrogation, and 30-day notice of cancellation. The schedule is enforced precisely; near-miss wording fails.
Problem 02 · Products tower
The standard $10M GPO floor is adequate for diagnostic equipment and lower-risk Class II devices. For implantables, neurostimulators, infusion pumps, and orthopedic implants, hospital procurement contracts and tort exposure both push toward $25M+ on the products tower. The ILF curve is reasonable past $10M; the structural decision is whether to layer through specialty MGAs or stay with admitted markets.
Long claim tails on implantables - sometimes 10-20 years between manufacture and claim - make occurrence-form coverage materially more valuable than claims-made. Some specialty markets only write claims-made above primary; verify each layer before binding.
Problem 03 · Connected devices
FDA premarket cybersecurity guidance has made cyber a baseline expectation for any device with software connectivity. Hospital procurement contracts now reference it explicitly. A standalone cyber policy with regulatory defense, notification expense, and ransomware coverage is standard for connected-device manufacturers.
The coordination question matters: a cyber event that causes a manufacturing defect (compromised firmware shipping out of spec) sits ambiguously between cyber and products liability. Programs written by carriers who play together avoid the coverage fight.
Problem 01 · GPO vendor schedule compliance
GPO supplier agreements require $5M general liability, $10M products liability, additional-insured wording for the GPO and member hospitals on a primary/non-contributory basis, waiver of subrogation, and 30-day notice - all enforced through Symplr/Reptrax credentialing.
Non-compliant uploads suspend purchasing within the cure period (typically 30 days). Most mid-market device manufacturers discover that the union of all GPO schedules is materially tougher than any single schedule and need to build to the strictest schedule.
Problem 02 · FDA recall response
Medical Device Reporting requires the manufacturer to notify FDA of malfunction and adverse event events that may have caused or contributed to death or serious injury. The reporting trigger creates a claim notification standard that some products policies do not align with by default.
Recall extension on the products policy is typically inadequate for a real Class I recall of a Class II/III device. Dedicated recall coverage at $3M-$10M first-party is standard for implantable, sterile, and high-risk device manufacturers.
Problem 03 · Cyber for connected devices
FDA cybersecurity guidance for medical devices applies to pre-market submissions and post-market surveillance. Connected devices (Bluetooth-enabled, networked, cloud-integrated) carry product cyber exposure where a cyber-induced device failure produces bodily injury or property damage.
Standard products policies do not address cyber-induced device failure. A product cyber endorsement on the products policy is required for any manufacturer with a connected-device portfolio. SaMD operators carry the heaviest cyber program in the medtech segment.
Problem 04 · Long-tail products exposure
Class III implantable devices, life-sustaining device categories, and certain Class II long-use products generate claim tails that can extend 10-20 years past sale. Standard claims-made products policies leave coverage gaps for delayed-injury claims; occurrence-form policies with appropriate aggregate management address the tail.
M&A diligence on device companies routinely surfaces inadequate tail coverage as a load-bearing issue. Programs should anticipate exit-event diligence by maintaining occurrence-form products throughout the company life.
Carrier access
Generalist manufacturer carriers will write a medical device manufacturer like a general industrial. The placement looks fine on the COI. The placement fails at first GPO credentialing audit, when it turns out the policy form excludes products tail or the cyber does not address SaMD.
Our placements run through carriers with dedicated medical device underwriting and, for implantable/life-sustaining categories, surplus-lines specialty markets. We know which carriers write Class III implantables at competitive terms vs which restrict appetite to Class I/II.
Programs anchored in Texas with broader placement across the major US life-sciences clusters - including the New Jersey pharma corridor and the North Carolina (RTP) cluster.
Pricing
Premium ranges for medical device manufacturers at $5M-$50M revenue, the factors that drive cost, and sample programs by FDA class and connectivity.
Frequently asked
Vizient, Premier, and HealthTrust all require $5M general liability and $10M products liability minimums, with $25M aggregate common for higher-risk implantables. Plus additional-insured/primary-noncontributory wording and 30-day notice.
Yes. Class II devices typically face higher products-liability stakes (510(k) clearance implies a duty of care around substantial equivalence). Class III adds PMA-level documentation and recall response coverage.
Increasingly yes - FDA cybersecurity guidance for premarket submissions has made cyber a baseline expectation, and hospital procurement contracts now reference it explicitly.
Coverage for bodily injury or property damage caused by your device after it leaves your control. For medical devices, the long claim tail (decades for implantables) makes occurrence-form coverage materially more valuable than claims-made.
Platforms like Symplr/Reptrax block purchases when COI requirements are not met. The product can be approved while the supplier is locked out due to documentation gaps. Vendors often discover this only when sales drop unexpectedly.
Standard products policies have limited recall extensions. A standalone product recall and contamination policy is recommended for finished-device manufacturers, particularly Class II implantables and Class III devices.
Next steps
Five cyber program structures by device class - connected device default, SaMD, contract manufacturer, PHI-handling device.
OpenFive questions about your operation. Get a single named coverage gap most likely to surface at first claim.
OpenField notes on how sponsor and GPO contract insurance and indemnity provisions have drifted.
OpenPaste 3 customer contract indemnity clauses. Get a verdict on the risk transfer architecture.
OpenAuthoritative references
The FDA QSR governing medical device manufacturers - now aligning toward ISO 13485.
International QMS standard required by global purchasers and increasingly by US GPOs.
Unique device identification - drives recall traceability and product-liability defense.
MDR adverse-event reporting obligations - claim notification standard for products policies.
Pre-market and post-market cyber expectations - shapes cyber liability scope for connected devices.
Why operators choose this practice
Every placement passes through specialty life-sciences underwriters - not a general manufacturer or healthcare desk.
Programs placed nationally with deep practice content for the 16 states anchoring the major US life-sciences clusters.
Coverage review requests come back the same business day. MSA reads are typically half an hour or less.
Free MSA Decoder, 49-clause glossary, 60+ Q&A library. Designed for CFOs, GCs, and Quality leaders.
Related deep-dives
Free coverage review
No marketing sequences, no list rental. Half-hour MSA reads are the standard.